We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.25B
AUM Growth
+$935M
Cap. Flow
+$872M
Cap. Flow %
20.54%
Top 10 Hldgs %
37.69%
Holding
613
New
34
Increased
490
Reduced
55
Closed
25

Top Buys

Rank Stock Value
1
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$78.8M
2
AAPL icon
Apple
AAPL
+$66.5M
3
NVDA icon
NVIDIA
NVDA
+$55.9M
4
MSFT icon
Microsoft
MSFT
+$53.9M
5
AMZN icon
Amazon
AMZN
+$37.1M

Top Sells

Rank Stock Value
1
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$17.1M
2
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$17.1M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$3.06M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$2.53M
5
PODD icon
Insulet
PODD
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 33.68%
2 Consumer Discretionary 10.52%
3 Healthcare 10.01%
4 Communication Services 9.79%
5 Financials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNP icon
376
CenterPoint Energy
CNP
$25.3B
$1.17M 0.03%
36,726
+8,708
+31% +$268K
CFG icon
377
Citizens Financial Group
CFG
$29B
$1.16M 0.03%
26,469
+6,219
+31% +$275K
ARWR icon
378
Arrowhead Research
ARWR
$9.5B
$1.16M 0.03%
61,503
-3,990
-6% -$82.2K
ONC
379
BeOne Medicines Ltd
ONC
$39.4B
$1.15M 0.03%
6,249
-189
-3% -$38.6K
WAB icon
380
Wabtec
WAB
$47.3B
$1.15M 0.03%
6,075
+1,238
+26% +$240K
ZBH icon
381
Zimmer Biomet
ZBH
$18.6B
$1.15M 0.03%
10,891
+2,485
+30% +$267K
RCKT icon
382
Rocket Pharmaceuticals
RCKT
$380M
$1.14M 0.03%
90,985
-20,469
-18% -$308K
MTB icon
383
M&T Bank
MTB
$33.4B
$1.14M 0.03%
6,075
+1,238
+26% +$246K
BRO icon
384
Brown & Brown
BRO
$22.2B
$1.14M 0.03%
11,183
+2,483
+29% +$265K
VLTO icon
385
Veralto
VLTO
$23.6B
$1.12M 0.03%
11,034
+2,484
+29% +$265K
IP icon
386
International Paper
IP
$18.1B
$1.12M 0.03%
20,785
+4,978
+31% +$267K
SBAC icon
387
SBA Communications
SBAC
$19.5B
$1.12M 0.03%
5,488
+1,243
+29% +$280K
MDGL icon
388
Madrigal Pharmaceuticals
MDGL
$12.2B
$1.12M 0.03%
3,620
-1,358
-27% -$382K
DOV icon
389
Dover
DOV
$25.6B
$1.11M 0.03%
5,939
+1,239
+26% +$242K
NTRS icon
390
Northern Trust
NTRS
$32.8B
$1.11M 0.03%
10,863
+2,486
+30% +$254K
SWTX
391
DELISTED
SpringWorks Therapeutics
SWTX
$1.11M 0.03%
30,811
+10,433
+51% +$365K
STE icon
392
Steris
STE
$20.7B
$1.1M 0.03%
5,374
+1,243
+30% +$273K
GH icon
393
Guardant Health
GH
$23.6B
$1.1M 0.03%
36,120
+3,553
+11% +$100K
MLYS icon
394
Mineralys Therapeutics
MLYS
$2.45B
$1.1M 0.03%
89,529
-33,969
-28% -$444K
EXPE icon
395
Expedia Group
EXPE
$34.9B
$1.09M 0.03%
5,844
+1,240
+27% +$214K
DAWN
396
DELISTED
Day One Biopharmaceuticals
DAWN
$1.09M 0.03%
85,761
+6,878
+9% +$95.7K
TRMB icon
397
Trimble
TRMB
$13.6B
$1.08M 0.03%
15,336
+3,631
+31% +$247K
MRNA icon
398
Moderna
MRNA
$58.7B
$1.07M 0.03%
25,765
-17,143
-40% -$819K
CMS icon
399
CMS Energy
CMS
$20.8B
$1.07M 0.03%
16,043
+3,730
+30% +$257K
CBOE icon
400
Cboe Global Markets
CBOE
$28B
$1.07M 0.03%
5,451
+1,243
+30% +$256K
14 15
16
17 18

Similar funds

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

NEOS Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, NEOS Investment Management held 613 positions worth $4.25B, up 28% from $3.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

NEOS Investment Management deployed $872M of net new capital in Q4 2024, opening 34 new positions and adding to 490 existing holdings. Its largest new stake was Palantir: 258,157 shares worth $19.5M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Insulet, an estimated $1.27M trimmed.

  • NEOS Investment Management's largest Q4 2024 buy was Palantir: 258,157 shares worth $19.5M.
  • NEOS Investment Management added most to Vanguard Russell 2000 ETF in Q4 2024, an estimated $78.8M increase.
  • NEOS Investment Management's biggest Q4 2024 reduction was Insulet, cutting an estimated $1.27M.
  • NEOS Investment Management fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q4 2024, selling an estimated $17.1M.
  • NEOS Investment Management's ten largest holdings make up 38% of its $4.25B portfolio in Q4 2024.
  • NEOS Investment Management opened 34 new positions and closed 25 in Q4 2024.
  • NEOS Investment Management's portfolio value rose 28% quarter-over-quarter to $4.25B.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.